Novo Nordisk and Eli Lilly will dominate the obesity drug market long-term, says Mizuho's Jared Holz

Jared Holz, Mizuho, joins 'Fast Money' to talk Novo Nordisk's recent climb.

Jan 24, 2025 | Health

Jared Holz, Mizuho, joins 'Fast Money' to talk Novo Nordisk's recent climb..

Back to Health Page